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Abstract : We investigated whether coronary artery calcium score （CAC） in the tar-
get lesion on the multidetector computed tomography angiography （CTA） predicts 
the addition of the Rotational atherectomy （Rota） during percutaneous coronary 
intervention （PCI）.  Lesion CAC on CTA were evaluated with quantitative coro-
nary analysis （QCA） on coronary angiography for predicting the Rota treatment 
in 114 consecutive patients （165 target lesions） with rst PCI （68 ± 9 years old, 
females: 17.6％）.  Rota was added in 8 patients （11 lesions）.  The lesion length 
and diameter stenosis on QCA, and lesion length and lesion CAC on CTA were 
the primary factors associated with the addition of Rota.  Using the cut-off value 
based on receiver operating characteristic analysis, the sensitivity and specicity for 
predicting the Rota based on QCA was 72.7％ in 8 of 11 lesions （vessels） with 
Rota and the specicity was 74％ in 114 of 154 without Rota in the lesion length 
of ≥ 23 mm （χ2＝ 10.9, p＝ 0.001）, and 54.5％ in 6 of 11 lesions with Rota and 
the specicity was 79.2％ in 122 of 154 without Rota in the diameter stenosis of ≥ 
83％ （χ2＝ 6.6, p＝ 0.01）.  Those based on CTA were 90.9％ in 10 of 11 lesions 
with Rota and 77.3％ in 119 of 154 without Rota in the lesion length of ≥ 34 mm 
（χ2＝ 24.1, p＜ 0.001）, and 90.9％ in 10 of 11 with Rota and 88.3％ in 136 of 
154 without Rota in the lesions with CAC ≥ 453 （χ2＝ 45.7, p＜ 0.001）.  Lesion 
CAC on CTA is most predictive of addition of Rota during PCI.
Key words : coronary artery disease, rotational atherectomy, multidetector computed 
tomography angiography, calcication, quantitative coronary angiographic 
analysis.
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Introduction
　Calcied coronary lesions represent an advanced stage in the atherosclerotic process whereby a 
soft plaque is converted to a brocalcic plaque.  The presence and severity of coronary artery 
lesion calcication impact the risk of subsequent coronary events and the success rate of percuta-
neous coronary intervention （PCI） in the obstructive coronary artery disease （CAD）.  Treatment 
of calcic lesions is challenging with higher rates of procedural failure, stent under-deployment, 
lower postprocedual minimal luminal diameter and acute gain, and an elevated risk of reste-
nosis 1, 2）.  Rotational atherectomy （Rota） has emerged to be a representative device for such 
calcied lesions.  Rota can facilitate smooth stent delivery and stent expansion through lesion 
modication 3-5）.  However, practice guidelines recommend the use of Rota for the treatment of 
heavily calcied or severely brotic lesions that cannot be bypassed by a balloon or adequately 
dilated before planned stenting during the PCI 6）. 
　On the other hand, electron beam tomography is a noninvasive method to quantify the extent 
of calcium formation in the coronary arteries.  Coronary artery calcium score （CAC） such as 
Agatston score 7） measured using multidetector computed tomography coronary angiography 
（CTA） can be used as an indicator of atherosclerotic burden 8）.
　In the present study, we retrospectively investigated whether quantitative calculating the CAC 
score in the target lesion by CTA could predict necessary of the use of Rota, before PCI in the 
CAD patients.
Subjects and methods
Populations
　For this retrospective cohort study we used the information in consecutive 150 patients （208 
target lesions） with CAD who was suspected by the CTA and underwent the percutaneous 
coronary intervention （PCI） within 6 months after the CTA from December 2010 to April 2014 
at Showa university Hospital.  The CAD was dened as the presence of at least one coronary 
lesion with ≥ 75％ luminal diameter stenosis of coronary artery on CAG, and PCI was planned 
in our hospital.  The patients with acute coronary syndrome or myocardial infarction who under-
went the intervention or coronary artery bypass grafting in the past were excluded from the 
present study.  Of those, 114 consecutive patients （165 target lesions） with rst PCI （the mean 
ages ± standard deviations : 68 ± 9 years old, females : 17.6％） were nally selected in the pres-
ent study.  All patients gave written informed consent before the interventions, and the protocol 
was approved by our Institutional Review Board.  Data collected retrospectively included : demo-
graphics, existing medical diagnoses, risk factors for cardiovascular disease, medications, previous 
cardiac procedures, and prior history of cardiac events.
QCA measurement on CAG and PCI with and without Rota
　The coronary artery stenosis was assessed by quantitative coronary analysis （QCA） with 
CAAS software （Version 5.10, Pie Medical Imaging, Maastricht, Netherlands）9）.  The target 
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vessel, target lesion and lesion length （mm） on CAG were dened as the stenotic site of more 
than 75％ using CAAS system.  The minimum vascular diameter （mm）, control vascular diam-
eter （mm）, and percent diameter stenosis （％） were also measured into target lesion.
　All patients were fully informed about the alternative treatment options and PCI-related risks 
before they provided written informed consent to undergo the procedure.  Furthermore, when 
the intravascular ultrasound （IVUS） catheter could not be passed through the severe lesions, 
when IVUS detected near-circumferential calcication, or when the lesion did not expand fol-
lowing balloon angioplasty, the final decision for Rota use was left to the discretion of the 
attending physician who was unaware of the calcied plaque conditions with CTA images.  Rota 
was performed with the Rota system （Boston Scientic Corporation, Natick, MA, U.S.A.）, with 
burr sizes from 1.25 to 2.25 mm.  The recommended burr speed was 180,000-200,000 rpm with 
each sequence being less than 30 seconds, and care was taken to prevent any drop in rotational 
speed ≥ 5000 rpm.  A continuous intracoronary infusion containing nicorandil, nitroglycerin and 
heparin was used to prevent and control slow-ow.  It was advised to use incremental burr sizes 
to achieve a burr-to-artery ratio of at least 0.7.  PCI was performed through the femoral artery 
approach by inserting a 7 Fr or 8 Fr guiding catheter under 10000 IU heparin intravenous 
administration by use of the approved systems （balloon length 10-40 mm）.  The technique to 
achieve an optimal angiographic result was determined by the operator.  The procedural success 
was dened as angiographically proven residual stenosis less than 50 ％ and stenosis reduction 
of at least 20％ 10）.  The use of stents for bail out （ow-limiting dissections, severe recoil, vessel 
closure） or unsatisfactory results （residual diameter stenosis ＞ 50％） was excluded from the 
present study.
CTA before CAG
　CTA study was performed using a 128-slice scanner （Somatom Denition AS ＋; Siemens 
Medical Solutions, Forchheim, Germany） before CAG.  The routine protocol for patients with 
suspected CAD included CAC measurement followed by noninvasive coronary angiography.  Cor-
onary calcium score was measured in a non–contrast-enhanced scan, quantied using the Calcium 
Score module of Syngo software （Siemens Medical Solutions） and expressed in Agatston units. 
Then, CTA studies were performed with a contrast-enhanced ECG gating, administering a β- 
blocker （a bolus injection of landiolol hydrochloride at a dose of 0.125 mg/kg） if the heart rate 
went above 70 beat/min.  Nitroglycerine was administered sublingually immediately before the 
bolus injection of contrast media （Omnipaque, 350 mg iodine/ml, Daiichi Sankyo Co, Ltd, Tokyo, 
Japan） into the antecubital vein, followed by a 20 ml saline solution chaser bolus.  The amount 
of the contrast media used for the scan was determined according to the patient’s body weight 
and scan time ［the total dose ＝ （scan time＋ 4 seconds）× 0.07 × body weight］.  The scan was 
gated to the cardiac cycle through ECG synchronization with the following parameters : col-
limation width, 64×0.6 mm ; rotation time, 330 ms ; tube voltage, 120 kV ; effective tube current, 
800 mA ; table feed, 11.5 mm/rotation ; and pitch 0.3.  ECG-gated data sets were nally recon-
structed with a slice thickness of 2.0 mm at the point of the cardiac cycle for every 5％ of R-R 
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interval.
Analysis of CTA and CAC measurements
　Scans were analyzed off-line on a dedicated workstation （Leonardo, Siemens Medical Solution） 
to measure the CAC and the stenotic degrees of coronary artery.  Each identified coronary 
artery lesion was assessed for stenosis severity along multiple longitudinal transverse, and oblique 
axes with the use of multiplanar reconstructions, thin-slab maximum intensity projections, and the 
curved reconstruction technique.  The coronary lesion’s severity was assessed by the maximum 
percent luminal diameter stenosis observed in any plane.  The Agatston score, both per patient, 
per vessel, and target lesion 7, 11） were measured for each patient.  The lesion length including 
calcied plaque was measured on the longitudinal images.  Two experienced observers, who were 
unaware of the patient’s clinical information, evaluated the CTA images independently.
Calcied plaque patterns on CTA
　Sharp reconstruction images were used for all plaque calcication analyses.  Window width and 
level settings were adjusted to the investigator’s discretion to optimally visualize the coronary artery 
lumen and to identify plaque calcication.  Calcium plaque within CAD lesions were dened as 
occupying at least three contiguous pixels with a density of ＞ 130 Hounseld units （HU）. 
Statistical analysis
　For descriptive purposes, the target lesions were divided into 2 groups on the basis of inter-
ventional treatment such as PCI with and without Rota.  All continuous variables are presented 
as mean ± SD.  Differences between groups were tested using an unpaired Student’s test or 
χ2 test.  The associations between the predictors, such as calcium plaque pattern of the target 
lesion on CTA, were formally tested by multivariable logistic regression analysis for CT one-
cross section of target lesion and one target lesion of coronary artery.  All multivariable analyses 
employed the forward stepwise method, with entry and removal probability values set at 0.5. 
Pearson’s correlation analysis was performed to assessment dependence.  All statistical analysis 
was completed using IBM SPSS for Windows version 20 （SPSS Inc., an IBM Company, Chicago, 
IL）.  A probability value of ＜ 0.05 was considered signicant.
Results
A case with Rota
　The CAG showed the coronary artery stenosis of ＞ 75％ in middle lesion of right coronary 
artery visually in 73-years-old woman （Fig. 1）.  QCA showed the following parameters of the 
23.6 mm of length of target lesion, 2.98 mm of reference diameter, 0.72 mm of minimal lumen 
diameter, and 76 ％ of diameter stenosis.  The catheter of IVUS did not pass through this target 
lesion, which indicated an extensively solid plaque with calcication.  The treatment of Rota was 
achieved at bar size of 1.75 mm, and the coronary stenting with ballooning was achieved.  The 
retrospective measurement of CAC on CTA was 2743.1 in the patient, 1698.1 in the target ves-
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sel, and 1034 in the target lesion.  The length of calcied plaque on CTA was 39.9 mm on the 
longitudinal images.
Patients and lesion characteristics
　In the present study, 106 patients underwent PCI without Rota and 8 patients with Rota, 
while in 4 patients the treatment as changed from PCI to Rota.  Furthermore, 4 patients had 
PCI in one vessel and Rota in other vessel （These patients were evaluated as having the Rota）. 
Among patient cohort, there was no signicant difference in age, gender, risk factors, and medi-
cations between the patients with and without Rota （Table 1）.
　The PCI was involved in 5 vessels with LMT, 72 vessels with LAD, 37 vessels with LCX, and 
51 vessels with RCA.  There is no signicant difference in the involved coronary artery area 
between the vessels with and without Rota （p ＝ 0.71） （Table 2）.  Concerning every vessels, the 
target lesions with Rota were signicantly longer lesion length （28.6 mm vs 20.5 mm, p＜ 0.01） 
and severe diameter stenosis （83.9％ vs 78.1％ , p＝ 0.05） on QCA, and higher CAC of target 
vessel and lesion （1078 vs 357 and 826 vs 176, p＜ 0.001 in each） and longer lesion length （45 
mm vs 26.4 mm, p＜ 0.001） on CTA than those without Rota.
The factors for predicting the Rota
　For continuous variables, the lesion length on QCA, and lesion length, and CAC in vessel and 
lesion on CTA were the primary factors associated with the Rota （Table 3）.  The lesion length 
was dependent on the diameter stenosis based on QCA with CAG （γ ＝ 0.591, p＜0.001）, and the 
lesion length on CTA was dependent on CAC in vessel and lesion based on CTA （γ ＝ 0.514 and 
0.537, p＜ 0.001 in each）.
Fig. 1.  The CAG showed the coronary artery stenosis of more than 75 ％ in the middle lesion of right coronary 
artery visually in 73 years old woman （Fig. 1）. The catheter of IVUS did not pass through this target lesion, 
and the coronary artery ballooning failed despite of high pressure, which indicated extensively solid plaque 
with calcification. The treatment of Rota was achieved successfully, and the coronary stenting with ballooning 
was achieved. The lesion CAC on CTA showed high score.
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Table 1.  Patient characteristics
Variable
Rota
p value
Yes  （n ＝ 8） No  （n ＝ 106）
Age （years） 73 ± 5 　 67 ± 10　 p ＝ 0.07
Female 1 （12.5％） 21 （19.8％） p ＝ 0.61
Diabetes 6 （75％） 41 （38.7％） p ＝ 0.21
Hypertension 4 （50％） 76 （71.7％） p ＝ 0.2
Hyperlipidemia 7 （87.5％） 53 （50％） p ＝ 0.16
Current smoking 7 （87.5％） 59 （55.7％） p ＝ 0.08
Familial history 2 （25％） 16 （15.1％） p ＝ 0.41
History of hemodialysis 1 （12.5％） 4 （3.8％） p ＝ 0.25
LVEF （％） 51.4 ± 23.2％ 60.1 ± 15.5％ p ＝ 0.14
Medications before MDCT
Use of beta blocker 1 （12.5％） 7 （6.6％） p ＝ 0.53
Use of angiotensin-II receptor blocker 5 （62.5％） 52 （49.4％） p ＝ 0.46
Use of statin 5 （62.5％） 38 （35.6％） p ＝ 0.13
Use of aspirin 1 （12.5％） 22 （20.8％） p ＝ 0.57
Abbreviations ; PCI＝Percutaneous coronary intervention, LVEF ＝ Left ventricular ejection fraction.
Table 2.  Vessel characteristics of CTA and CAG （QCA）
Variable
Rota
p value
Yes  （n ＝ 11） No  （n ＝ 154）
Involved coronary artery 
（LMT / LAD / LCX / RCA）
0 / 4 （36.4％） / 
2 （18.2％） / 5 （45.5％）
5 （3.2％） / 68 （44.2％） /
35 （22.7％） / 46 （29.9％）
p ＝ 0.71
QCA data of target lesion with CAG
　Lesion length （mm） 28.6 ± 8.1 20.5 ± 9.7 p ＝ 0.008
　Reference diameter （mm） 3.01 ± 0.46 2.99 ± 0.63 p ＝ 0.92
　Minimal lumen diameter （mm） 0.49 ± 0.25 0.66 ± 0.33 p ＝ 0.1
　Quantitative diameter stenosis （％） 83.9 ± 0.09 78.1 ± 0.1 p ＝ 0.05
CTA data of target lesion
　Visual diameter stenosis 
　（100％ / 99％ / 90％ / ＞ 90％）
2 （18.2％） / 0 /
6 （54.5％） / 3 （27.3％）
15 （9.7） /10 （6.5％） /
92 （59.7％） / 37 （24％）
p ＝ 0.68
CAC data with CTA 　 51.4 ± 23.2％ 　60.1 ± 15.5％ p ＝ 0.14
　in target vessel 1078 ± 516 357 ± 469 p ＜ 0.001 
　in target lesion （lesion CAC） 826 ± 324 176 ± 234 p ＜ 0.001
　Lesion length （mm）    45 ± 12.3 26.4 ± 13.2 p ＜ 0.001
Abbreviations ; LMT ＝ Left Main Trunk, LAD ＝ Left Anterior Descending Coronary Artery, LCX ＝ Left 
Circumex Coronary Artery, RCA ＝ Right Coronary Artery, QCA ＝ Quantitative Coronary Analysis on Coronary 
Angiography, CAG ＝ Coronary Angiography, CAC ＝ Coronary Artery Calcium score, CTA ＝ Multidetector Com-
puted Tomography Angiography.
55Calcified Plaque on CTA for Rotational Atherectomy
Table 3.  Factors for predicting Rota selection in continuous valuables
Regression 
analysis
Wald Univariate analysis
Variable Coefficient （beta） χ2 Odd ratio （95％ CI） p value
QCA data
　Lesion length （mm） （for increase） 0.064 6.22  1.07 （1.01-1.12）　 p ＝ 0.013
　Diameter stenosis （％） （for increase） 0.054 3.53  1.06 （1-1.12）  　 p ＝ 0.06
CTA data
　Lesion length （mm） （for increase） 0.068 13.42  1.07 （1.03-1.11） p ＜ 0.001
　CAC in target vessel （for increase） 0.002 14.41 1.002 （1-1.003）   　 p ＜ 0.001
　CAC of target lesion （lesion CAC） （for increase） 0.005 19.96 1.005 （1.003-1.007） p ＜ 0.001
Abbreviations ; Rota ＝ Rotational atherectomy, QCA ＝ Quantitative coronary analysis on coronary angiography, 
CTA ＝ Multidetector computed tomography angiography, CAC ＝ Coronary artery calcium score.
Fig. 2.  Based on ROC analysis, the optimal thresholds for the Rota selection in vessel were at the lesion length of 
23 mm （A） and stenosis diameter of 83％ （B） on QCA, and at the lesion length of 34 mm （C） and lesion 
CAC of lesion of 453 （D）. The sensitivity and specificity based on CTA were 90.9％ in 10 of 11 lesions with 
Rota and 77.3％ in 119 of 154 without Rota in the lesion length of ≥ 34 mm, and 90.9％ in 10 of 11with 
Rota and 88.3％ in 136 of 154 without Rota in the lesion CAC ≥ 453 （χ2 ＝ 45.7, p＜ 0.001）. The AUC 
for the prediction of Rota treatment was 0.953 in the lesion CAC on CTA, and it was the largest of the 
predictive factors.
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　Using the cut-off value based on ROC analysis （Fig. 2）, the sensitivity and specificity for 
predicting the Rota based on QCA was 72.7％ in 8 of 11 lesions （vessels） with Rota and the 
specicity was 74％ in 114 of 154 without Rota in the lesion length of ≥ 23 mm, and 54.5％ 
in 6 of 11 lesions with Rota and the specicity was 79.2％ in 122 of 154 without Rota in the 
diameter stenosis of ≥ 83％.  Similarly, the sensitivity and specicity based on CTA were 90.9％ 
in 10 of 11 lesions with Rota and 77.3％ in 119 of 154 without Rota in the lesion length of ≥ 
34 mm, and 90.9％ in 10 of 11with Rota and 88.3％ in 136 of 154 without Rota in the lesion 
CAC ≥ 453 （χ2 ＝ 45.7, p＜0.001）.  The area under ROC curve （AUC） in the lesion CAC for predict-
ing the Rota was the largest in the predictive factors.
Discussion
　In the present study, we showed that the target lesion CAC based on CTA was the most 
predictive of addition of the Rota during PCI. 
　Wang et al 12） demonstrated that a high CAC score （＞ 300） was a signicant predictor for 
major adverse cardiac events （MACE） in patients with stable angina pectoris who underwent 
PCI, which indicated the complexity of PCI because of severely calcied plaque ; however, that 
study did not clarify the best tool for the decision of Rota use.
　Practice guidelines recommend the use of Rota for the treatment of heavily calcified or 
severely fibrotic lesions that cannot be bypassed by a balloon or adequately dilated before 
planned stenting 13）.  Despite the signicant reduction of restenosis by Drug-eluting stent （DES）, 
several factors including diabetes, hemodialysis, and severe calcication have been reported to 
be high-risk factors for restenosis after DES implantation 14-20）.  Several studies have shown that 
DES implantation after the use of Rota reduced in the incident of target lesion revasculariza-
tion （TLR）21） and major adverse cardiac events 22-24）.  It is that lesion modication by the Rota 
could yield smooth stent delivery, prevent damage to the polymer coating 25）, and provide optimal 
stent expansion, all of which could help DES be effective, even for calcied lesions.  In addition, 
procedural success rates of over 90％ and complications less than 5％ are routinely achieved 
after Rota of calcified lesions 26-28）.  In the present study, no patient experienced emergency 
adverse events during PCI with the use of Rota such as a perforation of coronary artery and 
acute myocardial infarction, dissection of a coronary artery.
　Development of CTA has elevated the non-invasive diagnosis of coronary heart disease to a 
new level.  Particularly, in diagnosing calcication of coronary arteries, CTA has incomparable 
accuracy and allows quantication ; and the CAC score calculated using the automatic analysis 
software is favorably correlated, quantitatively, to the area of atherosclerotic plaques 7）.  However, 
arterial wall calcication may adulterate the results of CTA, reducing the specicity and positive 
predictive value. Diederichsen et al 29） reported that the diagnostic accuracy of CTA declined in 
patients with high CAC （Agatston score ＞ 400） and suggested that patients with CS ＞ 400 
should not undergo CTA.  On the other hand, Lau et al 30） found that a high CAC improved 
the sensitivity of CTA in detecting a stenotic coronary artery, without compromising specicity. 
Furthermore, in cross-sectional images, Cerci R et al 31） reported that 79％ of the plaques with ≥
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180 calcium arc had ＜ 50％ diameter of stenosis as dened by QCA and that 77％ of lesions 
without visible residual lumen had 50％ or greater lumen narrowing by QCA.  It is important 
for the operator to predict the target lesions which are heavily calcied and undilatable with 
balloon technology before PCI 17） because the attempts to treat these heavily calcified lesions 
with ballooning and stenting often lead to vessel dissection or incomplete stent deployment with 
adverse outcomes.  In the present study, we found that the target lesion CAC based on CTA 
was the most predictive of Rota addition during PCI with a sensitivity of 90.9％ and the speci-
city of 88.3％ in the lesion CAC ≥ 453 （χ2＝ 45.7, p＜ 0.001）. 
　In conclusion, lesion CAC on CTA is most predictive of addition of Rota during PCI.  The 
evaluation of CAC score on CTA is useful for indicating the addition of Rota.
　The addition of Rota is recommended to be performed only when the heavily calcied lesion 
was not crossed by a balloon catheter or adequately dilated before stent implantation 6）.  All the 
published prospective random control study that evaluated the various catheter-based coronary 
interventional devices excluded patients with severely calcied lesions 6）.  Therefore, the evidence 
base for best PCI practices in patients with severely calcied lesions comes from nonrandomized 
single-arm studies although several retrospective studies have shown that the use of Rota before 
the attempt of stenting with ballooning is safe and reasonable in patients with severely calcied 
lesions.  In the present study, the indication of Rota treatment was evaluated from CTA data 
retrospectively because of these reasons. Our results are based upon a single center experience 
with patients referred for CAD which may limit the more general application applicability of 
the ndings.  We also investigated the lesion calcied plaque on CTA as a predictor of Rota 
treatment in a limited number of patients. Thus, the evaluation of severely calcied plaque on 
CTA to decide the addition of Rota should be prospectively studied in the near future by a 
multicenter study.
　Hemodialysis is generally known to cause the severe coronary artery calcications, but only 5 
patients with the history of hemodialysis was performed rst PCI in the present study because 
the other patients with hemodialysis had been repeated PCI.  Thus, the PCI procedure for those 
patients with hemodialysis should be also evaluated in future studies, independent of patients 
with only atherosclerosis.
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